ICPAX | VENAX | ICPAX / VENAX | |
Total Expense Ratio | 1.50 | 0.09 | 1,667% |
Annual Report Gross Expense Ratio | 1.60 | 0.09 | 1,778% |
Fund Existence | 26 years | 21 years | - |
Gain YTD | 9.969 | 0.937 | 1,063% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 133M | 8.68B | 2% |
Annual Yield % from dividends | 0.87 | 3.27 | 27% |
Returns for 1 year | 14.24 | -5.38 | -265% |
Returns for 3 years | 32.05 | 11.43 | 280% |
Returns for 5 years | 158.62 | 143.68 | 110% |
Returns for 10 years | 34.70 | 25.58 | 136% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TSMG | 18.31 | 0.04 | +0.21% |
Leverage Shares 2X Long Tsm Daily ETF | |||
GMAY | 39.64 | 0.03 | +0.08% |
FT Vest U.S. Eq Mod Buffr ETF - May | |||
SBIO | 33.12 | 0.01 | +0.02% |
ALPS Medical Breakthroughs ETF | |||
CORP | 96.69 | -0.12 | -0.12% |
PIMCO Investment Grade Corporate Bd ETF | |||
BNDD | 12.19 | -0.09 | -0.74% |
Quadratic Deflation ETF |